Responses
Gastroduodenal
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial
Compose a Response to This Article
Other responses
No responses have been published for this article.